A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Príomhchruthaitheoir: | Sorno, Rubina Haque |
---|---|
Rannpháirtithe: | Khair, Nishat Zareen |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
Brac University
2024
|
Ábhair: | |
Rochtain ar líne: | http://hdl.handle.net/10361/23842 |
Míreanna comhchosúla
-
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
de réir: Flora, Sanzida Alam
Foilsithe / Cruthaithe: (2024) -
A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
de réir: Khan, Muidul Hasan
Foilsithe / Cruthaithe: (2024) -
In silico modelling and structural dynamics of PSY1R kinase domain and its interaction with SERK1 kinase
de réir: Ruhee, Noshin Nawer
Foilsithe / Cruthaithe: (2022) -
Arresting tumor cell proliferation and inhibition of AKT pathway via the use of multikinase inhibitor sorafenib forthe treatment of glioblastoma
de réir: Raju, Md. Ismail
Foilsithe / Cruthaithe: (2022) -
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
de réir: Ratu, Tabassum
Foilsithe / Cruthaithe: (2024)